ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Morgan Stanley Healthcare Conference in New York City. RxSight’s management is scheduled to present on Monday, September 8, 2025, at 7:45 a.m. Pacific Time / 10:45 a.m. Eastern Time. A live and archived webcast of the presentation will be avai ...

Company Overview - Mission Produce, Inc. is a global leader in sourcing, producing, and distributing fresh Hass avocados and mangos, serving retail, wholesale, and foodservice customers in over 25 countries [4] - The company has been in operation since 1983 and is vertically integrated, owning five state-of-the-art packing facilities across the U.S., Mexico, Peru, and Guatemala [4] - Mission Produce sources from over 20 premium growing regions, ensuring a year-round supply of premium fresh fruit [4] - The company's global distribution network includes strategically positioned forward distribution centers across key markets in North America, China, Europe, and the UK, offering value-added services [4] Financial Results Announcement - Mission Produce will release its financial results for the fiscal third quarter ended July 31, 2025, after the market closes on September 8, 2025 [1] - A conference call and webcast to discuss the financial results will be held at 5:00 PM Eastern Time on the same day [1] Conference Call Details - The conference call can be accessed live by dialing (877) 407-9039 for domestic callers and (201) 689-8470 for international callers [2] - A replay of the call will be available until September 22, 2025, with specific dialing instructions for both domestic and international callers [2] - The live audio webcast will be accessible on the Company's Investor Relations website, with an archived replay available shortly after the live event [3]

Core Viewpoint - Shenandoah Telecommunications Company (Shentel) will present at the Bank of America 2025 Media, Communications, & Entertainment Conference on September 3, 2025, at 9:40 AM E.T. [1] Company Overview - Shenandoah Telecommunications Company provides broadband services through high-speed fiber optic and cable networks to residential and commercial customers across eight contiguous states in the eastern United States [2] - The company's service offerings include broadband internet, video, voice, high-speed Ethernet, dark fiber leasing, and managed network services [2] - Shentel operates an extensive regional network with over 17,700 route miles of fiber [2]

Core Insights - Absci is advancing ABS-201, an AI-designed therapeutic antibody for treating androgenetic alopecia, with guidance from renowned dermatologists [1][4][5] - Androgenetic alopecia affects approximately 80 million Americans, with current FDA-approved treatments showing limited efficacy [2] - ABS-201 targets prolactin receptors to stimulate hair follicle regeneration, demonstrating superior hair regrowth compared to minoxidil in preclinical studies [3] Company Overview - Absci is a clinical-stage biotech company utilizing generative AI for drug discovery, aiming to create better biologics faster [7][8] - The company’s Integrated Drug Creation™ platform combines AI models with synthetic biology to innovate therapeutics [7] - Absci is headquartered in Vancouver, WA, with additional facilities in New York City and Switzerland [8] Scientific Advisory Board - Dr. Rodney Sinclair and Dr. David Goldberg have joined the ABS-201 Scientific Advisory Board, bringing extensive expertise in dermatology and hair loss [1][4][6] - Dr. Sinclair has over three decades of experience and has authored over 1000 publications in dermatology [4][5] - Dr. Goldberg has nearly four decades of clinical experience and has conducted pivotal research studies in hair loss, including original Minoxidil trials [5][6] Clinical Development - Phase 1/2a clinical trials for ABS-201 are set to begin in early 2026, with initial proof-of-concept data expected in the second half of 2026 [3] - The novel mechanism of action of ABS-201 offers potential for a durable therapy, addressing the limitations of current treatments that require continuous usage [5][6]

Company Participation in Financial Conferences - Flux Power Holdings, Inc. will participate in the H.C. Wainwright Annual Global Investment Conference on September 10, 2025, at Lotte NY Palace Hotel, New York, NY [1] - The company will also attend the Lake Street Big 9 Ideas Growth Conference on September 11, 2025, at The Yale Club, New York, NY [2] - CEO Krishna Vanka and CFO Kevin Royal will be available for meetings with registered attendees at both events [2] Company Overview - Flux Power designs, manufactures, and sells advanced lithium-ion energy storage solutions for various industrial and commercial sectors, including material handling and airport ground support equipment [3] - The company's lithium-ion battery packs offer a better performance, lower cost of ownership, and more environmentally friendly alternative compared to traditional lead-acid and propane-based solutions [3] - Flux Power's products contribute to reducing CO2 emissions and improving sustainability and ESG metrics for fleets [3]

Core Insights - Option Care Health is the largest independent provider of home and alternate site infusion services in the United States [2] Company Overview - Option Care Health employs over 8,000 team members, including more than 5,000 clinicians, dedicated to improving care standards for patients with acute and chronic conditions across all 50 states [2] - The company aims to enhance the infusion care experience through clinical leadership, expertise, and national scale [2] Upcoming Events - Option Care Health will participate in the Deutsche Bank Healthcare Summit in New York City from September 10 to September 11, 2025 [3] - The company will also be present at the Jefferies Healthcare Services Conference in Nashville on September 30, 2025, featuring a fireside chat at 1:15 PM CT / 2:15 PM ET [3]

BERKELEY, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, will participate in a fireside chat at the Citi 2025 Biopharma Back to School Conference on September 3, 2025 at 2:30 PM EDT. For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Carib ...

Core Viewpoint - Berkshire Hills Bancorp and Brookline Bancorp have received all necessary regulatory approvals to proceed with their merger, which will create a new entity named Beacon Financial Corporation, effective September 1, 2025 [1][2][3]. Group 1: Merger Details - The merger will result in a combined company valued at $24 billion, with over 145 branch offices serving the Northeast region [2]. - The regulatory approvals were granted by multiple authorities, including the Federal Reserve System and state banking departments [3]. - Shareholders of both companies approved the merger proposals during meetings held on May 21, 2025 [3]. Group 2: Leadership and Integration - Paul A. Perrault, CEO of Brookline, will lead the combined company as CEO, while David M. Brunelle of Berkshire will serve as Chairperson of the Board [4][5]. - The integration process is expected to be smooth, with both organizations having collaborated extensively in preparation for the merger [4]. Group 3: Brand Transition - Following the merger, the new entity will operate under the name Beacon Financial Corporation, with shares trading on the NYSE under the symbol "BBT" [5]. - Clients will continue to access services through their existing bank branches until a full transition to the Beacon Bank brand is completed, anticipated in the first quarter of 2026 [5][6].

EL SEGUNDO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, will hold a conference call on Tuesday, September 9, 2025, at 4:30 p.m. Eastern time to discuss results for the fiscal fourth quarter and full year ended June 30, 2025. Financial results will be issued in a press release prior to the call. A-Mark management will host the presentation, followed by a question-and-answer period. A-Mark’s conference cal ...

Core Insights - NN, Inc. has appointed Mohamad Farhat as the new Chief Technical Officer for its electrical, defense, and medical businesses, aiming to enhance innovation and customer solutions [1][2][3] Company Overview - NN, Inc. is a global diversified industrial company that specializes in engineering and manufacturing high-precision components and assemblies for various markets [4] Leadership and Strategy - The appointment of Mr. Farhat is part of NN's strategy to strengthen its technical capabilities and innovation focus, particularly in the electrical, defense, and medical sectors [2][3] - Tim French, COO, emphasized the importance of technology leadership in solving customer problems and expanding into new markets [3] Market Focus - NN has a distinct focus on electrical, defense, and medical products, with recent promotions within the company to enhance its Mobile Solutions segment, which targets automotive and industrial markets [2][3] Background of New CTO - Mohamad Farhat brings extensive experience in engineering leadership, having previously served as Vice President of Engineering for Commercial Vehicle Group, Inc., and held roles at Sumitomo, Rigaku, and Flex [3]